DANIŞ, N. Et Al. 2018. Paritaprevir+Ritonavir+Ombitasvir+Dasabuvir±Ribavirin treatment in HCV infected chronic hemodialysis patients: A single center experience. APASL .

DANIŞ, N., PULLUKÇU, H., YAMAZHAN, T., ERSÖZ, G., ÜNAL, N. G., GÜNŞAR, F., ... TURAN, İ.(2018). Paritaprevir+Ritonavir+Ombitasvir+Dasabuvir±Ribavirin treatment in HCV infected chronic hemodialysis patients: A single center experience . APASL

DANIŞ, NİLAY Et Al. "Paritaprevir+Ritonavir+Ombitasvir+Dasabuvir±Ribavirin treatment in HCV infected chronic hemodialysis patients: A single center experience," APASL, 2018

DANIŞ, NİLAY Et Al. "Paritaprevir+Ritonavir+Ombitasvir+Dasabuvir±Ribavirin treatment in HCV infected chronic hemodialysis patients: A single center experience." APASL , 2018

DANIŞ, N. Et Al. (2018) . "Paritaprevir+Ritonavir+Ombitasvir+Dasabuvir±Ribavirin treatment in HCV infected chronic hemodialysis patients: A single center experience." APASL .

@conferencepaper{conferencepaper, author={NİLAY DANIŞ Et Al. }, title={Paritaprevir+Ritonavir+Ombitasvir+Dasabuvir±Ribavirin treatment in HCV infected chronic hemodialysis patients: A single center experience}, congress name={APASL}, city={}, country={}, year={2018}}